Gewinn- und Verlustrechnung von The Clorox Company

CL's fundamentals are supported by global diversification, emerging-market growth and Hill's strength, while CLX leans on recovery and GOJO.

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Clorox and General Mills are still working through company-specific challenges. Constellation's Modelo and Corona brands may help support cash flow while it reduces debt.

Business boomed during the pandemic, but since the economic reopening, it has been one difficulty after another for Clorox (CLX -0.30%).

The Clorox Company (NYSE: CLX - Get Free Report)'s share price reached a new 52-week low during trading on Wednesday. The stock traded as low as $80.84 and last traded at $81.1970, with a volume of 219475 shares changing hands. The stock had previously closed at $81.60. Wall Street Analysts Forecast Growth A number of brokerages

CLX's innovation, GOJO acquisition and digital transformation are strengthening its health and hygiene portfolio while supporting long-term growth.

Investors need to pay close attention to CLX stock based on the movements in the options market lately.

The Clorox Company (CLX) trades at a depressed 14x forward P/E and offers a 6% dividend yield, but faces ongoing macro and execution headwinds. Despite a brighter FY27 outlook, CLX's near-term organic growth and margin expansion remain challenged by inflation, weak volumes, and integration risks from the GOJO acquisition. I maintain a hold rating, as a turnaround appears at least 12–24 months away, with upside hinging on cost synergies, successful integration, and margin recovery.

The new B2B-focused business, created through the combination of CloroxPro and GOJO, Makers of Purell, brings professional and healthcare customers unparalleled access to the most trusted health and hygiene solutions in the industry. OAKLAND, Calif.

Clorox has raised its dividend for decades, but a cratering stock price, a payout ratio management calls elevated, and a debt load that ballooned after two major deals raise a pointed question about whether that streak survives fiscal 2027.